BeOne Medicines
ONC
#530
Rank
NZ$83.20 B
Marketcap
NZ$728.41
Share price
-0.97%
Change (1 day)
15.59%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2026 (TTM): NZ$14.40

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is NZ$14.93. In 2025 the company made an earnings per share (EPS) of NZ$4.98 an increase over its 2024 EPS that were of NZ-$11.37.

EPS history for BeOne Medicines from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$14.40189.43%
2025NZ$4.98-143.75%
2024NZ-$11.37
2022NZ-$35.5428.21%
2021NZ-$27.72-19.96%
2020NZ-$34.6320.81%
2019NZ-$28.6731.52%
2018NZ-$21.80417.57%
2017NZ-$4.21-37.16%
2016NZ-$6.70158.95%
2015NZ-$2.59

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
NZ-$0.35-102.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
NZ-$1.73-111.60%๐Ÿ‡บ๐Ÿ‡ธ USA